Opinion on Pharmaceuticals and Healthcare in Spain

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

Antipsychotics: growth in sales but only until 2006

Published By Datamonitor
20 Apr 2001
ResearchWire
ResearchWire

Arthritis: sales will hit $24 billion in 2007

Published By Datamonitor
23 Apr 2001
ResearchWire
ResearchWire

Pharmacoeconomics: half of studies are based on cost-effectiveness

Published By Datamonitor
03 May 2001
ResearchWire
ResearchWire

Dyslipidemia: sales to increase 50% by 2007

Published By Datamonitor
04 May 2001
ResearchWire
ResearchWire

Colorectal cancer: sales to top $1 billion by 2007

Published By Datamonitor
08 May 2001
ResearchWire
ResearchWire

Pharmacoeconomics: cost 5% of R&D budget

Published By Datamonitor
09 May 2001
ResearchWire
ResearchWire

Pharmaceuticals: widespread belief that pharmacoeconomics can reduce R&D costs

Published By Datamonitor
14 May 2001
ResearchWire
ResearchWire

Vinka alkaloids: market to fall 17% by 2007

Published By Datamonitor
16 May 2001
ResearchWire
ResearchWire

Cardiovascular advertising: dyslipidemia is 97% of spend

Published By Datamonitor
17 May 2001
ResearchWire
ResearchWire

Out-licensing: marketing power and disease expertise are key factors in choice of partner

Published By Datamonitor
18 May 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

No help is available.